‘The easy problems have been solved’: How an Alphabet spinout looks to speed drug development

Former Google CEO Eric Schmidt, Salesforce CEO Marc Benioff and others are investors in the company, which is pushing quantum technology and AI-backed simulation software it says can accelerate drug discovery.
Click here to view original post

Advertisement — Advertise with Biotech Networks